Published in J Immunol on November 12, 2010
CD5-dependent CK2 activation pathway regulates threshold for T cell anergy. J Immunol (2012) 0.92
Developmental expression of B cell molecules in equine lymphoid tissues. Vet Immunol Immunopathol (2016) 0.75
Thymic selection of CD4+CD25+ regulatory T cells induced by an agonist self-peptide. Nat Immunol (2001) 12.00
Thymus and autoimmunity: production of CD25+CD4+ naturally anergic and suppressive T cells as a key function of the thymus in maintaining immunologic self-tolerance. J Immunol (1999) 8.98
CD4+CD25+ T cells inhibit both the induction and effector function of autoreactive T cells and represent a unique lineage of immunoregulatory cells. J Immunol (1998) 7.31
A regulatory B cell subset with a unique CD1dhiCD5+ phenotype controls T cell-dependent inflammatory responses. Immunity (2008) 6.73
Antiphosphocholine antibodies found in normal mouse serum are protective against intravenous infection with type 3 streptococcus pneumoniae. J Exp Med (1981) 6.45
A primitive T cell-independent mechanism of intestinal mucosal IgA responses to commensal bacteria. Science (2000) 5.78
Marginal zone and B1 B cells unite in the early response against T-independent blood-borne particulate antigens. Immunity (2001) 4.92
Identification of a B-1 B cell-specified progenitor. Nat Immunol (2006) 4.52
B-1 and B-2 cell-derived immunoglobulin M antibodies are nonredundant components of the protective response to influenza virus infection. J Exp Med (2000) 3.89
Launching the T-cell-lineage developmental programme. Nat Rev Immunol (2008) 3.86
CD5 expression is developmentally regulated by T cell receptor (TCR) signals and TCR avidity. J Exp Med (1998) 3.82
Origins and functions of B-1 cells with notes on the role of CD5. Annu Rev Immunol (2001) 3.65
Identification and characterization of circulating human transitional B cells. Blood (2005) 3.62
Natural antibodies with the T15 idiotype may act in atherosclerosis, apoptotic clearance, and protective immunity. J Clin Invest (2000) 3.51
A critical role of natural immunoglobulin M in immediate defense against systemic bacterial infection. J Exp Med (1998) 3.32
IL-5-deficient mice have a developmental defect in CD5+ B-1 cells and lack eosinophilia but have normal antibody and cytotoxic T cell responses. Immunity (1996) 3.23
Positive selection of natural autoreactive B cells. Science (1999) 2.91
A role for CD5 in TCR-mediated signal transduction and thymocyte selection. Science (1995) 2.84
B cell chronic lymphocytic leukemia: lessons learned from studies of the B cell antigen receptor. Annu Rev Immunol (2001) 2.55
Toll-like receptor 7-dependent loss of B cell tolerance in pathogenic autoantibody knockin mice. Immunity (2006) 2.36
B-1 cells: the lineage question revisited. Immunol Rev (2000) 2.06
Fine tuning of TCR signaling by CD5. J Immunol (2001) 2.02
Immunological unresponsiveness characterized by increased expression of CD5 on peripheral T cells induced by dendritic cells in vivo. Immunity (2004) 1.99
A developmental switch in B lymphopoiesis. Proc Natl Acad Sci U S A (1991) 1.96
An unbiased analysis of V(H)-D-J(H) sequences from B-1a, B-1b, and conventional B cells. J Immunol (1997) 1.94
Treatment of murine CD5- B cells with anti-Ig, but not LPS, induces surface CD5: two B-cell activation pathways. Int Immunol (1991) 1.90
CD5-mediated negative regulation of antigen receptor-induced growth signals in B-1 B cells. Science (1996) 1.84
The calcineurin phosphatase complex modulates immunogenic B cell responses. Immunity (2006) 1.83
Human CD5 promotes B-cell survival through stimulation of autocrine IL-10 production. Blood (2002) 1.69
Sensory adaptation in naive peripheral CD4 T cells. J Exp Med (2001) 1.65
Identification and characterization of a human CD5+ pre-naive B cell population. J Immunol (2009) 1.59
CD5 maintains tolerance in anergic B cells. J Exp Med (2000) 1.42
The lymphocyte glycoprotein CD6 contains a repeated domain structure characteristic of a new family of cell surface and secreted proteins. J Exp Med (1991) 1.41
Defective B-1 cell development and impaired immunity against Angiostrongylus cantonensis in IL-5R alpha-deficient mice. Immunity (1996) 1.40
A differentiation pathway for B1 cells in adult bone marrow. Proc Natl Acad Sci U S A (2009) 1.39
Spontaneously Ig-secreting B-1 cells violate the accepted paradigm for expression of differentiation-associated transcription factors. J Immunol (2005) 1.33
Phenotypic and functional characterization of c-kit expression during intrathymic T cell development. J Immunol (1992) 1.30
Functional activity of natural antibody is altered in Cr2-deficient mice. J Immunol (2002) 1.29
Notch2 haploinsufficiency results in diminished B1 B cells and a severe reduction in marginal zone B cells. J Immunol (2003) 1.28
B-cell activation by crosslinking of surface IgM or ligation of CD40 involves alternative signal pathways and results in different B-cell phenotypes. Proc Natl Acad Sci U S A (1995) 1.27
Lymphocyte populations and immune responses in CD5-deficient mice. Eur J Immunol (1994) 1.25
Induction of B-cell development in adult mice reveals the ability of bone marrow to produce B-1a cells. Blood (2009) 1.21
CD5 acts as a tyrosine kinase substrate within a receptor complex comprising T-cell receptor zeta chain/CD3 and protein-tyrosine kinases p56lck and p59fyn. Proc Natl Acad Sci U S A (1992) 1.20
Adult BM generates CD5+ B1 cells containing abundant N-region additions. Eur J Immunol (2009) 1.18
Activation of T lymphocytes by immobilized monoclonal antibodies to CD3. Regulatory influences of monoclonal antibodies to additional T cell surface determinants. J Clin Invest (1988) 1.18
The accessory molecules CD5 and CD6 associate on the membrane of lymphoid T cells. J Biol Chem (2002) 1.09
CD5 inhibits signaling at the immunological synapse without impairing its formation. J Immunol (2003) 1.06
Cutting edge: critical role for CD5 in experimental autoimmune encephalomyelitis: inhibition of engagement reverses disease in mice. J Immunol (2004) 1.05
An NFAT-dependent enhancer is necessary for anti-IgM-mediated induction of murine CD5 expression in primary splenic B cells. J Immunol (1998) 1.02
CD5 is associated with the human B cell antigen receptor complex. Eur J Immunol (1994) 1.01
Signaling through CD5 activates a pathway involving phosphatidylinositol 3-kinase, Vav, and Rac1 in human mature T lymphocytes. Mol Cell Biol (1998) 0.98
Normal B-1a cell development requires B cell-intrinsic NFATc1 activity. Proc Natl Acad Sci U S A (2003) 0.97
Differences in the repertoire expressed by peritoneal and splenic Ly-1 (CD5)+ B cells. J Immunol (1990) 0.96
Increased numbers of thymic and peripheral CD4+ CD25+Foxp3+ cells in the absence of CD5 signaling. Eur J Immunol (2009) 0.96
CD6: expression during development, apoptosis and selection of human and mouse thymocytes. Int Immunol (2002) 0.96
Evidence for an association between the T cell receptor/CD3 antigen complex and the CD5 antigen in human T lymphocytes. Eur J Immunol (1992) 0.95
The Bw cells, a novel B cell population conserved in the whole genus Mus. J Immunol (2007) 0.93
Transcriptional regulation of human CD5: important role of Ets transcription factors in CD5 expression in T cells. J Immunol (2004) 0.87
Activation of bovine B cells via surface immunoglobulin M cross-linking or CD40 ligation results in different B-cell phenotypes. Immunology (2000) 0.86
Induction of CD5 on B and T cells is suppressed by cyclosporin A, FK-520 and rapamycin. Int Immunol (1995) 0.86
CD5 provides viability signals to B cells from a subset of B-CLL patients by a mechanism that involves PKC. Leuk Res (2006) 0.85
The regulation of CD5 expression in murine T cells. BMC Mol Biol (2001) 0.85
Adult bone marrow contains precursors for CD5+ B cells. Eur J Immunol (1996) 0.85
Efficient generation of transgenic BALB/c mice using BALB/c embryonic stem cells. J Immunol Methods (1999) 0.84
Molecular and genetic insights into T cell antigen receptor signal transduction. Adv Exp Med Biol (1994) 0.81
NOD/SCID mice engrafted with human peripheral blood lymphocytes can be a model for investigating B cells responding to blood group A carbohydrate determinant. Transpl Immunol (2003) 0.80
Peritoneal B-cell development depends on strain, radiation, and time. Exp Hematol (2001) 0.78
Molecular linkage of the mouse CD5 and CD6 genes. Immunogenetics (1996) 0.77
Acute myeloid leukemia induced by graded reduction of a lineage-specific transcription factor, PU.1. Nat Genet (2004) 4.45
Origins and functions of B-1 cells with notes on the role of CD5. Annu Rev Immunol (2001) 3.65
Ovarian cancer progression is controlled by phenotypic changes in dendritic cells. J Exp Med (2012) 2.85
Toll-like receptor 7-dependent loss of B cell tolerance in pathogenic autoantibody knockin mice. Immunity (2006) 2.36
Uncovering growth-suppressive MicroRNAs in lung cancer. Clin Cancer Res (2009) 2.19
Conditional expression of heterozygous or homozygous Jak2V617F from its endogenous promoter induces a polycythemia vera-like disease. Blood (2010) 2.16
Type 3 deiodinase is critical for the maturation and function of the thyroid axis. J Clin Invest (2006) 1.95
Transcriptional interference by independently regulated genes occurs in any relative arrangement of the genes and is influenced by chromosomal integration position. Mol Cell Biol (2002) 1.78
Transgenic cyclin E triggers dysplasia and multiple pulmonary adenocarcinomas. Proc Natl Acad Sci U S A (2007) 1.61
The gene locus encoding iodothyronine deiodinase type 3 (Dio3) is imprinted in the fetus and expresses antisense transcripts. Endocrinology (2002) 1.45
Developmental- and differentiation-specific patterns of human gamma- and beta-globin promoter DNA methylation. Blood (2007) 1.17
Immune-mediated regression of established B16F10 melanoma by intratumoral injection of attenuated Toxoplasma gondii protects against rechallenge. J Immunol (2012) 1.16
Sialic acid binding domains of CD22 are required for negative regulation of B cell receptor signaling. J Exp Med (2002) 1.11
Decreased replication origin activity in temporal transition regions. J Cell Biol (2009) 1.09
Avirulent Toxoplasma gondii generates therapeutic antitumor immunity by reversing immunosuppression in the ovarian cancer microenvironment. Cancer Res (2013) 1.06
Transcriptional interference among the murine beta-like globin genes. Blood (2006) 1.06
Two new isotype-specific switching activities detected for Ig class switching. J Immunol (2002) 1.06
CD22 attenuates calcium signaling by potentiating plasma membrane calcium-ATPase activity. Nat Immunol (2004) 1.03
Genetic model for the chronic activation of skeletal muscle AMP-activated protein kinase leads to glycogen accumulation. Am J Physiol Endocrinol Metab (2006) 0.99
Deletion of the core region of 5' HS2 of the mouse beta-globin locus control region reveals a distinct effect in comparison with human beta-globin transgenes. Blood (2005) 0.99
Genetic deletion of mouse platelet glycoprotein Ibbeta produces a Bernard-Soulier phenotype with increased alpha-granule size. Blood (2004) 0.97
Normal B-1a cell development requires B cell-intrinsic NFATc1 activity. Proc Natl Acad Sci U S A (2003) 0.97
Age-associated decline in resistance to Babesia microti is genetically determined. J Infect Dis (2004) 0.95
Erythroid cell-specific alpha-globin gene regulation by the CP2 transcription factor family. Mol Cell Biol (2005) 0.95
Nanomolecular targeting of dendritic cells for ovarian cancer therapy. Future Oncol (2009) 0.94
The Trypanosoma cruzi trans-sialidase is a T cell-independent B cell mitogen and an inducer of non-specific Ig secretion. Int Immunol (2002) 0.92
Modeling the influence of vitamin D deficiency on cigarette smoke-induced emphysema. Front Physiol (2013) 0.90
Histone hyperacetylation within the beta-globin locus is context-dependent and precedes high-level gene expression. Blood (2009) 0.89
CpG hypomethylation in a large domain encompassing the embryonic beta-like globin genes in primitive erythrocytes. Mol Cell Biol (2007) 0.88
Dosage of X-linked Toll-like receptor 8 determines gender differences in the development of systemic lupus erythematosus. Eur J Immunol (2014) 0.88
Chromatin insulation by a transcriptional activator. Proc Natl Acad Sci U S A (2003) 0.87
Quantification of magnetic nanoparticles with low frequency magnetic fields: compensating for relaxation effects. Nanotechnology (2013) 0.86
Promoters of the murine embryonic beta-like globin genes Ey and betah1 do not compete for interaction with the beta-globin locus control region. Proc Natl Acad Sci U S A (2003) 0.86
Genomic imprinting variations in the mouse type 3 deiodinase gene between tissues and brain regions. Mol Endocrinol (2014) 0.84
Phagocytes mediate targeting of iron oxide nanoparticles to tumors for cancer therapy. Integr Biol (Camb) (2013) 0.84
Local tumour hyperthermia as immunotherapy for metastatic cancer. Int J Hyperthermia (2014) 0.83
Complex developmental patterns of histone modifications associated with the human beta-globin switch in primary cells. Exp Hematol (2009) 0.83
Developmentally regulated extended domains of DNA hypomethylation encompass highly transcribed genes of the human beta-globin locus. Exp Hematol (2009) 0.83
Exposure to Cigarette Smoke Disrupts CCL20-Mediated Antimicrobial Activity in Respiratory Epithelial Cells. Open Immunol J (2009) 0.82
Babesia microti primarily invades mature erythrocytes in mice. Infect Immun (2006) 0.82
An embryonic stage-specific enhancer within the murine β-globin locus mediates domain-wide histone hyperacetylation. Blood (2011) 0.80
Deletion of the Chd6 exon 12 affects motor coordination. Mamm Genome (2010) 0.79
Stimulating antitumor immunity with nanoparticles. Wiley Interdiscip Rev Nanomed Nanobiotechnol (2014) 0.78
Site controlled transgenic mice validating increased expression from human matrix metalloproteinase (MMP-1) promoter due to a naturally occurring SNP. Matrix Biol (2009) 0.76